cimetidine has been researched along with B. burgdorferi Infection in 1 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cimetidine (CIM) is an over-the-counter histamine-2 (H2) antagonist that is primarily used to lower acid secretions in the stomach." | 5.51 | Cimetidine as a novel adjunctive treatment for early stage Lyme disease. ( Shemenski, J, 2019) |
| "Cimetidine (CIM) is an over-the-counter histamine-2 (H2) antagonist that is primarily used to lower acid secretions in the stomach." | 1.51 | Cimetidine as a novel adjunctive treatment for early stage Lyme disease. ( Shemenski, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shemenski, J | 1 |
1 other study available for cimetidine and B. burgdorferi Infection
| Article | Year |
|---|---|
Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
Topics: Anti-Bacterial Agents; Autoimmunity; Borrelia burgdorferi; Cimetidine; Cytokines; Histamine H2 Antag | 2019 |